Organ-On-a-Chip
Market (OOC) is expected to hold a value of USD 115.9
Million by 2030 at a CAGR of 11.80%.
Organ-on-a-chip
(OOC) technology is a rapidly developing field that is poised to revolutionize
drug discovery and development, as well as personalized medicine.
Organ-on-a-chip devices are essentially miniature versions of human organs,
which are created using microfabrication techniques and can be used to model
the behavior of human organs in vitro. These devices offer several advantages
over traditional cell culture models, including more accurate predictions of
drug efficacy and toxicity, as well as the ability to study complex disease
processes.
The global
organ-on-a-chip market is growing owing to various reasons, such as an increase
in the number of collaborative sales agreements between pharmaceutical
companies and university spin-offs and the availability of advanced models of
OOCs in the market. The anticipated launch of advanced organ-specific models
and human-on-chip models is expected to further increase the growth rate of
this market during the review period.
Several market
players currently dominate the global organ-on-a-chip market. The key players
are involved in product launches and acquisitions to strengthen their market
positions.
Segment Analysis
The global organ on a chip market has been
segmented based on organ type, application, and end-user.
The global organ-on-a-chip market has been
segregated, based on organ type, into lung-on-chip, heart-on-chip,
liver-on-chip, intestine-on-chip, kidney-on-chip, skin-on-chip, blood-brain
barrier-on-chip, human-on-chip, and others.
The market based on application has been
branched into drug discovery, toxicology research, and others. The drug discovery segment is
expected to hold the largest share of the market due to the increased
application of OOCs by pharmaceutical companies in drug discovery and clinical trials for the different chronic therapeutic areas. The toxicology
research segment holds the second-largest share owing to increased R&D,
government initiatives and funding for research institutes, and universities on
OOCs in toxicology research and drug testing.
By end-user, the market has been classified as
pharmaceutical companies, research organizations, and others. The
pharmaceutical company’s segment is the largest segment owing to the rise in
the number of pharmaceutical companies using OOCs for their R&D and drug
toxicity and efficacy testing. The research organization segment is the
second-largest segment owing to major universities, research organizations,
non-profit research centers that are focusing on the application of OOCs in
drug toxicology testing. For instance, the Wyss Institute received almost USD
5.6 million in grant money from the US FDA to use its organ-on-chip technology
to test human physiological responses to radiation and to evaluate drugs
designed to counter those effects in 2017.\
Major Key
Players:
Some of the Organ-on-a-Chip Market Players are CN Bio Innovations
Limited (UK), Emulate, Inc. (US), TissUse GmbH (Germany), MIMETAS BV
(Netherlands), Hµrel Corporation, Nortis, Inc. (US), InSphero (Switzerland),
TARA Biosystems, Inc. (US), Axosim (US), Organovo Holdings Inc. (US), BioIVT
(US), and HemoShear Therapeutics, LLC (US).
Regional Analysis
The market has been divided, by
region, into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa. The Americas is expected to be the largest market owing to the high
prevalence of chronic diseases. The organ-on-a-chip market in the Americas has
further been branched into North America and Latin America, with the North
American market divided into the US and Canada. The European organ-on-a-chip
market has been categorized as Western Europe and Eastern Europe. The Western
European market has further been classified as Germany, France, the UK, Italy,
Spain, and the rest of Western Europe. The organ-on-a-chip market in
Asia-Pacific has been segmented into Japan, China, India, South Korea,
Australia, and the rest of Asia-Pacific.
Asia-Pacific is the
fastest-growing region in the market. This is mainly due to the increased
application of OOCs for drug screening for the treatment of various chronic
diseases and a supportive regulatory framework in Asia-Pacific. Such favorable
factors are expected to boost market growth during the forecast period.
The organ-on-a-chip market in the
Middle East & Africa has been divided into the Middle East and Africa.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
